Does tumor size improve the accuracy of prognostic predictions in node-negative gastric cancer (pT1-4aN0M0 stage)?

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Xu, Mu ^a   Huang, Chang Ming ^a   Zheng, Chao Hui ^a   Li, Ping ^a   Xie, Jian Wei ^a   Wang, Jia Bin ^a   Lin, Jian Xian ^a   Lu, Jun ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NODE NEGATIVE GASTRIC CANCER; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; SURVIVAL PREDICTION; TUMOR INVASION; TUMOR VOLUME; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL;

FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR BURDEN;

EID: 84903880074     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101061     Document Type: Article

References (28)

1. Ahmedin J, Rebecca S, Elizabeth W, Yong-ping H, Jia-quan X, et al. (2008) Cancer statistics 2008. CA Cancer J Clin 58 (2): 71-96.
2. Desai AM, Pareek M, Nightingale PG, Fielding JW (2004) Improving outcomes in gastric cancer over 20 years. Gastric Cancer 7(4): 196-201.
3. Kunisaki C, Shimada H, Nomura M, Matsuda G, Otsuka Y, et al. (2004) Surgical outcome of serosa-negative advanced gastric carcinoma. Anticancer Res 24(5B): 3169-75.
4. Kunisaki C, Shimada H, Nomura M, Matsuda G, Otsuka Y, et al. (2005) Clinical impact of metastatic lymph node ratio in advanced gastric cancer. Anticancer Res 25(2B): 1369-75.
5. Lee CC, Wu CW, Lo SS, Chen JH, Li AF, et al. (2007) Survival predictors in patients with node-negative gastric carcinoma. J Gastroenterol Hepatol 22:1014-8.
6. Huang KH, Chen JH, Wu CW, Lo SS, Hsieh MC, et al. (2009) Factors affecting recurrence in node-negative advanced gastric cancer. J Gastroenterol Hepatol 24(9):1522-6.
7. Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS (2003) Biologic predictors of survival in node-negative gastric cancer. Ann Surg 237(6):828-35.
8. Bruno L, Nesi G, Montinaro F, Carassale G, Boddi V, et al. (2000) Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer. J Surg Oncol 74(1): 30-2.
9. Baiocchi GL, Tiberio GA, Minicozzi AM, Morgagni P, Marrelli D, et al. (2010) A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg 252(1): 70-3.
10. Deng J, Liang H, Sun D, Zhang R, Zhan H, et al. (2008) Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence. Can J Gastroenterol 2(10): 835-9.
11. Sobin LH, Wittekind CH (2002) TNM: Classification of Malignant Tumors. 6th ed. New York: Wiley-Liss.
12. Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14: 101-112.
13. Washington K (2010) 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 17: 3077-3079.
14. Chen L, Oh SJ, Kim S, Hyung WJ, Yan M, et al. (2009) Risk Factors of Survival and Surgical Treatment for Advanced Gastric Cancer with Large Tumor Size. J Gastrointest Surg 13(5):881-885.
15. Ichiyoshi Y, Toda T, Minamisono Y, Nagasaki S, Yakeishi Y, et al. (1990) Recurrence in early gastric cancer. Surgery 107: 489-495.
16. Orita H, Matsusaka T, Wakasugi K, Kume K, Fujinaga Y, et al. (1992) Clinicopathologic evaluation of recurrence in early gastric cancer. Surg Today 22: 19-23.
17. Shiozawa N, Kodama M, Chida T, Arakawa A, Tur GE, et al. (1994) Recurrent death among early gastric cancer patients: 20-years' experience. Hepatogastroenterology 41: 244-247.
18. Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, et al. (2007) Recurrence in early gastric cancer-presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence. Hepatogastroenterology 54: 620-624.
19. Hyung WJ, Lee JH, Choi SH, Min JS, Noh SH (2002) Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol 9: 562-7.
20. Yokota T, Ishiyama S, Saito T, Teshima S, Yamada Y, et al. (2002) Is tumor size a prognostic indicator for gastric carcinoma?. Anticancer Res 22(6B):3673-7.
21. Wang X, Wan F, Pan J, Yu GZ, Chen Y, et al. (2008) Tumor Size: A Non-Neglectable Independent Prognostic Factor for Gastric Cancer. Journal of Surgical Oncology 97:236-240.
22. Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, et al. (2006) Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer. Am J Surg 192:296-300.
23. Liu X, Xu Y, Long Z, Zhu H, Wang Y (2009) Prognostic Significance of Tumor Size in T3 Gastric Cancer. Ann Surg Oncol 16(7):1875-1882.
24. Saito H, Kuroda H, Matsunaga T, Fukuda K, Tsujitani S, et al. (2010) Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol 101(7): 622-5.
25. Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS (2002) Biologic Predictors of Survival in Node-Negative Gastric Cancer. Annals of Surgery 237(6): 828-837.
26. Chen HC, Chu RY, Hsu PN, Hsu PI, Lu JY, et al. (2003) Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett 201:97-106.
27. Kopfstein L, Christofori G (2006) Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci 63:449-68.
28. Yu P, Rowley DA, Fu YX, Schreiber H (2006) The role of stroma in immune recognition and destruction of well-established solid tumors. Curr Opin Immunol 18:226-31.